Cited by CrossRef (19)
- Maria Kalli, Triantafyllos Stylianopoulos. Toward innovative approaches for exploring the mechanically regulated tumor-immune microenvironment. 2024;8
- Hyunseok Kong, Sang Bum Kim. Exosomal Communication Between the Tumor Microenvironment and Innate Immunity and Its Therapeutic Application. Immune Netw 2022;22
- Yuchen Qi, Xiang Zhao, Yan Dong, Min Wang, Junyi Wang, Zhichao Fan, Qin Weng, Hua Yu, Jianjun Li. Opportunities and challenges of natural killer cell-derived extracellular vesicles. Front. Bioeng. Biotechnol. 2023;11
- Mingyang Jiang, Ke Zhang, Jinfeng Meng, Linhua Xu, Ying Liu, Ruqiong Wei. Engineered exosomes in service of tumor immunotherapy: From optimizing tumor‐derived exosomes to delivering CRISPR/Cas9 system. Intl Journal of Cancer 2024
- Yu‐Long Lan, Shuang Zou, Wen Wang, Qi Chen, Yongjian Zhu. Progress in cancer neuroscience. MedComm 2023;4
- Minseon Lee, Soonjo Kwon. Cytochalasin B‐Induced Membrane Vesicles of NK Cells for Efficient Tumor Immunotherapy. Advanced Therapeutics 2024;7
- Yimin E, Chen Lu, Kuixuan Zhu, Wenyuan Li, Jing Sun, Pengcheng Ji, Minjie Meng, Zhengxia Liu, Chunzhao Yu. Function and mechanism of exosomes derived from different cells as communication mediators in colorectal cancer metastasis. iScience 2024;27:109350
- Shabnam Babaei, Manouchehr Fadaee, Hajar Abbasi-kenarsari, Dariush Shanehbandi, Tohid Kazemi. Exosome-based immunotherapy as an innovative therapeutic approach in melanoma. Cell Commun Signal 2024;22
- Bai Lv, Yifan Zhao, Yan Liang, Jie Cao. Extracellular vesicles: An advanced delivery platform for photosensitizers in tumor photodynamic therapy. Chemical Engineering Journal 2024;498:155438
- Jin-Yuan Liu, Zi-Li Yu, Qiu-Yun Fu, Lin-Zhou Zhang, Jin-Bang Li, Min Wu, Bing Liu, Gang Chen. Immunosuppressive effect of small extracellular vesicle PD-L1 is restricted by co-expression of CD80. Br J Cancer 2023;129:925
- Karol Sadowski, Wioletta Olejarz, Grzegorz Basak. Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment. IJMS 2022;23:15006
- Ali Hazrati, Sara Soudi, Kosar Malekpour, Mohammad Mahmoudi, Arezou Rahimi, Seyed Mahmoud Hashemi, Rajender S. Varma. Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications. Biomark Res 2022;10
- David Schweer, Annabel McAtee, Khaga Neupane, Christopher Richards, Frederick Ueland, Jill Kolesar. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy. Cancers 2022;14:2220
- Mara Zippoli, Anna Ruocco, Rubina Novelli, Francesca Rocchio, Martina Sara Miscione, Marcello Allegretti, Maria Candida Cesta, Pier Giorgio Amendola. The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance. Front. Oncol. 2022;12
- Hanchae Cho, Inseong Jung, Hyunji Ju, Moon-Chang Baek, Kyungmoo Yea. Engineered CD8+ T cell-derived extracellular vesicles induce enhanced anti-cancer efficacy and targeting to lung cancer cells. Cytokine 2023;169:156249
- Hyung Seok Kim, Jung Hwan Yoon, Geum Ok Baek, Moon Gyeong Yoon, Ji Eun Han, Hyo Jung Cho, Soon Sun Kim, Jee-Yeong Jeong, Jae Youn Cheong, Jung Woo Eun. Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma. Cancers 2023;15:4156
- Inseong Jung, Sanghee Shin, Moon-Chang Baek, Kyungmoo Yea. Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications. Exp Mol Med 2024
- Chaozhi Tang, Yuling Zhang. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review. Pathology - Research and Practice 2024;262:155518
- Si-Heng Zhang, Ling-Long Peng, Yi-Fei Chen, Yan Xu, Vahid Moradi. Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy. Inflamm Regener 2024;44